RAYANMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RAYANMED
Largest movements
- Cash -€50,084
down €50,084 (-96.4%), from €51,948 to €1,863
mainly Receivables within one year (-€37,712) and Net result for the year (-€10,835)
- Receivables within one year +€37,712
up €37,712 (+863.2%), from €4,369 to €42,081
of which Other amounts receivable: +€37,505
- Profit (loss) carried forward -€10,835
down €10,835 (-30.5%), from €35,531 to €24,697
- Trade debts -€709
no longer reported in 2025 (was €709)
- Tax, wage and social debts -€660
down €660 (-28.1%), from €2,351 to €1,692
- Gross operating margin -€17,871
down €17,871, from €10,061 to -€7,810
- Taxes -€1,358
down €1,358 (-80.9%), from €1,678 to €320
- Depreciation -€809
no longer reported in 2025 (was €809)
- Other operating charges +€582
up €582 (+28.5%), from €2,044 to €2,626
- Financial charges -€112
down €112 (-58.9%), from €191 to €79
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €56,892 | €44,688 | -€12,204 | -21.5% |
| Fixed assets | 21/28 | €575 | €575 | = | 0.0% |
| Financial fixed assets | 28 | €575 | €575 | = | 0.0% |
| Current assets | 29/58 | €56,317 | €44,113 | -€12,204 | -21.7% |
| Amounts receivable within one year | 40/41 | €4,369 | €42,081 | +€37,712 | +863.2% |
| Trade receivables | 40 | - | €207 | +€207 | |
| Other amounts receivable | 41 | €4,369 | €41,874 | +€37,505 | +858.4% |
| Cash at bank and in hand | 54/58 | €51,948 | €1,863 | -€50,084 | -96.4% |
| Deferred charges and accrued income | 490/1 | - | €169 | +€169 | |
| Total equity and liabilities | 10/49 | €56,892 | €44,688 | -€12,204 | -21.5% |
| Equity | 10/15 | €53,831 | €42,996 | -€10,835 | -20.1% |
| Contributions | 10/11 | €18,291 | €18,291 | = | 0.0% |
| Reserves | 13 | €9 | €9 | = | 0.0% |
| Non-distributable reserves | 130/1 | €9 | - | -€9 | |
| Other | 1319 | €9 | - | -€9 | |
| Distributable reserves | 133 | - | €9 | +€9 | |
| Profit (loss) carried forward | 14 | €35,531 | €24,697 | -€10,835 | -30.5% |
| Amounts payable | 17/49 | €3,061 | €1,692 | -€1,369 | -44.7% |
| Amounts payable within one year | 42/48 | €3,061 | €1,692 | -€1,369 | -44.7% |
| Trade debts | 44 | €709 | - | -€709 | |
| Suppliers | 440/4 | €709 | - | -€709 | |
| Taxes, remuneration and social security | 45 | €2,351 | €1,692 | -€660 | -28.1% |
| Taxes | 450/3 | €2,351 | €1,692 | -€660 | -28.1% |
| Remuneration, social security and pensions | 62 | -€111 | - | +€111 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €809 | - | -€809 | |
| Other operating charges | 640/8 | €2,044 | €2,626 | +€582 | +28.5% |
| Gross operating margin | 9900 | €10,061 | -€7,810 | -€17,871 | |
| Operating profit (loss) | 9901 | €7,319 | -€10,436 | -€17,755 | |
| Financial charges | 65/66B | €191 | €79 | -€112 | -58.9% |
| Recurring financial charges | 65 | €191 | €79 | -€112 | -58.9% |
| Profit (loss) for the period before taxes | 9903 | €7,128 | -€10,515 | -€17,642 | |
| Income taxes | 67/77 | €1,678 | €320 | -€1,358 | -80.9% |
| Profit (loss) for the period | 9904 | €5,449 | -€10,835 | -€16,284 | |
| Profit (loss) for the period to be appropriated | 9905 | €5,449 | -€10,835 | -€16,284 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.